Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
KBPC157 (100 g, 10 g or 10 ng/kg b.w.) was applied (i.p.) simultaneously or 15 minutes before application of the convulsive agents (mg/kg b.w., i.p.) picrotoxine (3), strychnine (6, 3 or 1.5), bicuculline (2.5) and isoniazide (800 mg)
New developments in pediatric dosing: 3D printed medication Addressing the unique medication needs of pediatric patients has been a challenge in drug mass production
When you have somebody going back to what you're saying about them being in dire mm-hmm
B12 deficiency can mask or coexist with folate deficiency both should be assessed
Bridging the Gap: From Animal Models to Human Efficacy The most critical challenge and primary direction for future BPC-157 research is the transition from compelling animal and in vitro data to validated human efficacy and safety
Common Pitfalls We've Seen (And How to Avoid Them) Over the years, our team has heard a few horror stories and coached many researchers through common mistakes
